Cargando…
Generation and Characterization of a JAK2V617F-Containing Erythroleukemia Cell Line
The JAK2V617F mutation is found in the majority of patients with myeloproliferative neoplasms (MPNs). Transgenic expression of the mutant gene causes MPN-like phenotypes in mice. We have produced JAK2V617F mice with p53 null background. Some of these mice developed acute erythroleukemia. From one of...
Autores principales: | Zhao, Wanke, Zou, Kang, Farasyn, Taleah, Ho, Wanting Tina, Zhao, Zhizhuang Joe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103785/ https://www.ncbi.nlm.nih.gov/pubmed/25036984 http://dx.doi.org/10.1371/journal.pone.0099017 |
Ejemplares similares
-
JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell lines
por: Zhao, Wanke, et al.
Publicado: (2012) -
Cardiac hypertrophy associated with myeloproliferative neoplasms in JAK2V617F transgenic mice
por: Shi, Kaiyao, et al.
Publicado: (2014) -
Relevance of JAK2V617F positivity to hematological diseases - survey of samples from a clinical genetics laboratory
por: Zhao, Wanming, et al.
Publicado: (2011) -
Development of a highly sensitive method for detection of JAK2V617F
por: Zhao, Anna H, et al.
Publicado: (2011) -
Thrombopoietin is required for full phenotype expression in a JAK2(V617F) transgenic mouse model of polycythemia vera
por: Spivak, Jerry L., et al.
Publicado: (2020)